Find links to guidance and information on all topics related to COVID-19, including the COVID-19 vac

Jun 25, 2024 · People with COVID-19 have a wide range of symptoms ranging from mild symptoms to severe illness. Symptoms may appear 2-14 days after exposure to the virus. Symptoms may start as mild, and some people will progress to more severe symptoms.

CDC’s home for COVID-19 data. Visualizations, graphs, and data in one easy-to-use website.

COVID-19 (coronavirus disease 2019) is a disease caused by the SARS-CoV-2 virus. It can be very contagious and can spread quickly. As of June 1, 2024, nearly 1.2 million people have died of COVID-19 in the U.S.

Dec 20, 2024 · A COVID-19 vaccine is the first step to prevent severe health outcomes. Antiviral treatments are not a replacement for COVID-19 vaccinations. COVID-19 vaccines available in the United States effectively protect people from getting …

Jul 12, 2024 · Wearing a mask and putting distance between yourself and others can help lower the risk of COVID-19 transmission. Testing for COVID-19 can help you decide what to do next, like getting treatment to reduce your risk of severe illness and taking steps to lower your chances of spreading COVID-19 to others.

Jun 13, 2024 · COVID-19 can vary from asymptomatic infection to critical illness. Symptoms and severity can change during illness. Information about clinical management and treatment of COVID-19 is categorized by severity of illness.

Las personas con COVID-19 tienen una amplia gama de síntomas que van de síntomas leves a enfermedades graves. Los síntomas pueden aparecer de 2 a 14 días después de la exposición al virus. Los síntomas pueden empezar siendo leves, y en algunas personas se intensificarán hasta llegar a ser graves.

Dec 6, 2024 · Weekly updated estimates of COVID-19-related symptomatic illnesses, outpatient visits, hospitalizations, and deaths in the United States, starting October 1, 2024, help us understand how COVID-19 is impacting people’s health.

Aug 19, 2024 · COVID-19 activity continues to increase in many parts of the country. KP.3.1.1, of the Omicron family, is now the predominant SARS-CoV-2 variant circulating in the United States, having overtaken its parent linage KP.3 and previous KP.2 variants.